Virtu Financial LLC Adma Biologics, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$3.12 - $4.22 $77,014 - $104,166	24,684 New	24,684 $91,000
Q3 2022 Nov 07, 2022	BUY	$2.03 - $2.86 $38,438 - $54,154	18,935 Added 110.16%	36,123 $88,000
Q2 2022 Aug 09, 2022	BUY	$1.43 - $2.2 $24,578 - $37,813	17,188 New	17,188 $34,000
Q1 2022 May 17, 2022	SELL	$1.28 - $1.83 $113,043 - $161,616	-88,315 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.09 - $1.66 $96,263 - $146,602	88,315 New	88,315 $125,000
Q4 2020 Feb 24, 2021	SELL	$1.8 - $2.56 $168,669 - $239,884	-93,705 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$2.04 - $3.74 $191,158 - $350,456	93,705 New	93,705 $224,000
Q1 2018 May 14, 2018	SELL	$3.21 - $5.21 $74,433 - $120,809	-23,188 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$2.06 - $3.24 $47,767 - $75,129	23,188	23,188 $74,000

326

190M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.31B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.